Effect of home exposure to Staphylococcus aureus on asthma in adolescents To the Editor:
Asthma is a major public health problem, particularly among inner-city minority children and adolescents. Indoor home environmental exposures to allergens and gram-negative endotoxin are established drivers of asthma morbidity in this population. 1 Although there has been recent interest in whether microbial dysbiosis can drive asthma morbidity, less is known about the role of specific environmental bacteria in asthma. One bacterium that can affect asthma control through environmental exposure is the Gram-positive Staphylococcus aureus, which often persists on surfaces and in home dust. 2 Colonization with S aureus is known to worsen eczema and has been linked to asthma symptoms. 3, 4 Interestingly, S aureus also can have effects through both IgE-independent 5 and IgE-dependent 6 inflammatory host responses. Although this evidence offers the potential for S aureus and staphylococcal enterotoxins (SEs) to affect asthma control, no prior study has evaluated whether home environmental staphylococcal exposures can affect this disease.
We evaluated the prevalence of environmental exposures to S aureus and SEs by quantifying S aureus and SE genes in home dust extracts in a large multicenter population of inner-city adolescents with asthma, and we sought to determine whether these exposures were associated with respiratory symptoms, an inflammatory biomarker, and lung function. Furthermore, because prior studies have linked S aureus colonization to eczema severity, 4 we also explored whether a history of eczema, which could be a proxy for host responsiveness to SA or SE exposures, had the potential to modify associations between SEs and asthma outcomes.
We performed a cross-sectional secondary data analysis and laboratory assessment of existing samples in the completed Asthma Control Evaluation (ACE) trial (NCT00114413). 7 Analysis was limited to participants and home dust samples from the home visit after recruitment with at least 250 mL of home dust extract available for analysis.
We evaluated self-reported respiratory symptoms, fraction of exhaled nitric oxide (FENO), and lung function (FEV 1 percent predicted and FEV 1 /forced vital capacity percentage) at the randomization clinic visit conducted within 3 weeks of the home visit from which the home dust extracts were derived. We measured bacterial genes for S aureus (femB) and 3 SE genes (SEA through SEC) in home dust extract aliquots using a real-time PCR method we previously adapted and optimized for use in such specimens. 8 Additional details on study design, sample population, laboratory assessment, statistical methods, and regulatory oversight are available in the Methods section in this article's Online Repository at www.jacionline.org.
Demographic, household, and respiratory outcome characteristics of the 424 adolescent participants with asthma from the ACE population included in this analysis are provided in Table E1 in this article's Online Repository at www.jacionline.org and demonstrate that this sample population consisted disproportionately of low-income minority adolescents and that there were no significant differences among the 424 included participants compared with the 122 not examined, as shown in Fig E1 in this article's Online Repository at www.jacionline.org.
Genes for S aureus and SEs were detectable in most home dust extracts, as described in Table E2 in this article's Online Repository at www.jacionline.org. S aureus genes were detected in 81% of homes, and 1 or more SE genes were detected in 74% of homes. Allergen concentrations were typically only weakly correlated with S aureus/SE gene copy numbers, as shown in Table E3 and described in the Results section in this article's Online Repository at www.jacionline.org.
We calculated associations between home environmental S aureus and SE exposures and respiratory outcomes, an inflammatory biomarker, and lung function in the children and adolescents. Table I provides estimates for these adjusted associations between continuous S aureus and SE exposures and respiratory outcomes and shows that exposures to increasing concentrations of any SE and total SE concentrations were associated with increased odds for having a day with reduced activity. However, S aureus and SE concentrations in home dust were not associated with worse FENO values or lung function. Unadjusted associations and sensitivity analyses are described in Table E4 and in the Results section in this article's Online Repository.
We explored whether a history of eczema, an allergic disease in which exacerbations are associated with S aureus, could modify the relationship between S aureus or SE exposures and respiratory outcomes. Table E5 in this article's Online Repository at www.jacionline.org provides estimates of association between continuous measures of S aureus and SEs and asthma outcomes stratified into the 148 participants who reported a history of eczema and the 276 participants who did not report a history of eczema and shows that among those without a history of eczema, higher settled dust SEA concentrations tended to be associated To our knowledge, this is the first study to evaluate the prevalence and concentrations of environmental S aureus and SEs in a multicenter population of inner-city adolescents with asthma. More than 80% of the adolescents we evaluated in the multicenter ACE study were exposed to a detectable number of S aureus genes in home dust in this population. Exposures to detectable numbers of SE genes in home dust also were common in this study, ranging from 36% (SEB and SEC) to more than 60% (SEA). Although there is a growing literature on detection of S aureus, particularly methicillin-resistant Staphylococcus aureus, in the home environment related to infection outcomes, 2 few prior studies have evaluated S aureus in the home environment in the context of asthma, 8, 9 and none have done so in this population. Given that staphylococcal exposures can induce inflammation through both IgE-dependent and independent mechanisms, this finding can have important implications for asthma among inner-city adolescents. This study's findings support the hypothesis that environmental SE exposures have the potential to elicit asthma symptoms, although results were not uniform across outcomes. Environmental exposures to SEA were associated consistently with multiple symptom outcomes among asthmatic patients without eczema, which was the opposite of our hypothesis that asthmatic patients with eczema would have worse disease. A growing literature supports the biological plausibility of inflammatory responses and illness from environmental staphylococcal exposures. Limitations of the study were that the cross-sectional assessment precluded demonstration of causal relationships and that gene detection was used as a proxy for bacterial and protein exposures. The Discussion section in this article's Online Repository at www.jacionline.org provides additional discussion regarding history of eczema, biological plausibility, and study limitations.
Given the novelty of these findings, it is important to pursue future research to replicate these results in other populations and to conduct prospective longitudinal studies to evaluate whether environmental exposures to SEs can be causally associated with asthma morbidity. Furthermore, the finding that SEA home environmental exposures were associated with worse disease among participants who did not report a history of eczema suggests that host susceptibility might be important to this relationship. Future work should focus on elucidating host susceptibility factors and understanding the potential mechanism or mechanisms by which SE could be associated with asthma symptoms.
We thank the Inner-City Asthma Consortium for sharing of home dust extracts and data. We also thank Dr John Groopman and his research group, particularly Pat Egner, for their support. Liver disease predicts mortality in patients with X-linked immunodeficiency with hyper-IgM but can be prevented by early hematopoietic stem cell transplantation
To the Editor: X-linked immunodeficiency with hyper-IgM (XHIM) is a severe primary immunodeficiency disorder characterized by low levels of, or absence of IgG, IgA, and IgE, with normal to raised serum IgM concentrations.
1 XHIM results from mutations in the CD40 ligand (CD40L) gene found on activated CD4 T cells 2 ; disruption of this gene results in aberrant interaction with CD40 on B-cell membranes, thus inhibiting B-cell proliferation and immunoglobulin class switching.
3 CD40 is also found on other cells such as
METHODS

Study design
We performed a cross-sectional secondary data analysis and laboratory assessment of existing samples in the completed ACE trial (NCT00114413): a 10-center randomized, controlled trial that enrolled inner-city adolescents with asthma and tested the addition of exhaled nitric oxide to inform treatment step prescription on asthma control outcomes. The inclusion/exclusion criteria and conduct of this study have been described previously in detail.
E1, E2 We restricted our analysis to home dust samples collected at the home visit after recruitment and to participant data collected at the recruitment clinic visit (demographic data) or at the randomization clinic visit (outcome data), which occurred at the end of a 3-week run-in period to characterize participants, establish treatment, and evaluate adherence.
Outcomes in adolescents
Subjective symptoms were assessed through three 2-week symptom recall questions (higher symptom report indicates worse asthma) and the Asthma Control Test, which is a set of questions over a 4-week recall (lower score indicates worse asthma). E3,E4 Objective measures of respiratory health were assessed by using FENO, a measure of pulmonary inflammation E5 ; FEV 1 ; and FEV 1 /forced vital capacity ratio.
E6
History of eczema
Insufficient serum was available from a pretreatment visit in the ACE study to test for SE-specific IgE. Therefore we evaluated a surrogate measure, eczema (atopic dermatitis), that we hypothesized could be associated with responsiveness to S aureus. Participants were coded as yes (1) 
Laboratory assessment
Home dust extracts had been used previously for analysis of common household allergen concentrations. In remaining aliquots available for analysis, we measured bacterial genes for S aureus (femB) and 3 SE genes (SEA through SEC) using a real-time PCR method we adapted previously and optimized for use in such specimens. E7 Briefly, DNA was isolated from 250 to 500 mL of home dust extracts by using BiOstic Bacteremia Kits (MoBio Laboratories, Carlsbad, Calif), and then bacterial DNA was amplified with previously published primers for S aureus and SEA through SEC genes in a series of 3 duplex reactions: femB with each of 3 SE genes. E8 Repetition of the femB assessment was used as an internal quality control measure. Cycle threshold values from real-time PCR were transformed into gene copy numbers by using plasmid standards, normalization of the count per gram of dust (accounting for the initial volume of dust extract from which DNA was extracted), and imputation of values less than the limit of detection (as limit of detection/sqrt 2), as previously described.
E7
Statistical analysis
Continuous variables were log-transformed, as indicated for skewed data (ie, FENO values). Unadjusted and adjusted linear or binomial logistic regression models were used to evaluate associations between gene copy numbers detected in home dust extracts and respiratory outcomes. Associations with continuous log gene copy numbers were assessed to evaluate the potential for a dose-response effect between S aureus/SE and respiratory outcomes. In addition, binary S aureus/SE exposures (any detection vs no detection) were evaluated. Given that no variables were available to assess potential sensitization to SE allergens, we also explored whether outcomes differed according to history of eczema, which we hypothesized to represent a subset of participants who might have greater responsiveness to S aureus, SEs, or both and which we hypothesized would be more likely to express respiratory outcomes with increasing concentrations of S aureus/SEs in home dust. All analyses were performed in Stata 13 software (StataCorp, College Station, Tex).
Regulatory oversight
The ACE trial was approved by the institutional review boards of all participating institutions. The institutional review board of the Johns Hopkins Bloomberg School of Public Health determined that use of the specimens linked to anonymized data available to the public was exempt from further review.
RESULTS
Among 546 adolescent participants with asthma in the ACE population who completed the randomization clinic and home visits, 424 (78%) had sufficient home dust extract remaining to complete laboratory and data analysis (see Fig E1 and Table E1 ). We calculated the correlation between home dust extract measures of allergen concentration and S aureus/SE gene copy numbers in the same samples, as shown in Table E3 . Generally, S aureus/SE exposures were weakly correlated or not correlated with concentrations of pet or pest allergens in the home dust extracts. Predictably, S aureus and SE exposures were often moderately correlated with each other and hence were analyzed separately or in aggregate (summation of the normalized concentrations of each SE gene per gram of dust).
Unadjusted associations between home environmental S aureus and SE exposures and respiratory outcomes, an inflammatory biomarker, and lung function in the children and adolescents were similar or stronger than adjusted associations and are provided in Table E4 . Inclusion of all pet and pest allergen concentrations in the adjusted continuous models as a sensitivity analysis did not affect the direction or significance of associations between S aureus/SE exposures and respiratory outcomes. Given multiple comparisons, we also performed a sensitivity analysis controlling for false discovery rate in the adjusted continuous models. Under these more rigorous assumptions, we would have failed to reject the null hypothesis for both significant findings with FEV percent predicted and for total SE and reports of nights woken by asthma. For all significant models estimating associations between SE exposures and reduced activity and for the significant association between SEC and nights woken by asthma, the inference (statistical significance) did not change when we controlled for false discovery rate.
Among participants with a history of eczema, higher settled dust SEA concentrations tended to be associated with fewer days of asthma symptoms, whereas among those without a history of eczema, higher settled dust SEA concentrations tended to be associated with more days of asthma symptoms. This was true for models that evaluated continuous metrics of S aureus/SE exposure, as well as models that evaluated binary S aureus or SE detection versus nondetection; inflammatory biomarker and lung function results for binary models (data not shown in Fig 1) were similar to the continuous models presented in Table E5 . The interactions between SEA concentrations and eczema were statistically significant for all symptom outcomes except one. Eczema status did not modify the relationship between SEA concentrations and FENO values or lung function.
We evaluated whether the finding that eczema modified the association between settled dust SEA concentrations and asthma symptoms could be due to differences in SEA exposure between participants with and without a history of eczema. Participants with and without a history of eczema were not significantly more or less likely to be exposed to SEA, SEB, or SEC. However, only 34 (8%) adolescent participants were exposed to SEB and not SEA, and 84 (20%) adolescent participants were exposed to detectable concentrations of all 3 SEs tested. Inclusion of all SE variables in the same model as a sensitivity analysis yielded similar results to models in which SEs were considered independently.
DISCUSSION
This study found that S aureus and SE genes, SEA in particular, could be detected in the majority of homes of inner-city adolescents with asthma. More than 80% of the adolescents we evaluated in the multicenter ACE study were exposed to a detectable number of S aureus genes in home dust in this population. Exposures to detectable numbers of SE genes in home dust were also common in this study, ranging from 36% (SEB and SEC) to more than 60% (SEA). We previously used dust samples collected from the homes of 24 urban adults with asthma to adapt and validate the laboratory methodology to conduct this work; in this small single-center convenience sample, detection of S aureus was also frequent (96%), and SE detection ranged from 25% (SEA) to 63% (SEB and SEC).
E7
Future studies should evaluate differences in SE exposures by population, time period, and geographic location, given the known diversity of S aureus strains, each of which might or might not carry enterotoxin genes.
E9
Although it is established that infection with S aureus induces inflammation and that ingestion of SEs is associated with gastrointestinal illness, E10 there is a growing literature that supports the biological plausibility of inflammatory responses and illness from environmental staphylococcal exposures. Inhalation of staphylococcal superantigens has been linked to both upper and lower respiratory effects in both mouse models and accidental human exposures. E11-E15 In laboratory settings an intranasal dose as low as 20 ng elicited inflammatory responses in mice. E12 In human subjects skin and mucosal exposures also have been linked to induction of inflammation. E13,E16 Because the dust used in this study was obtained from the bed and bedroom floor of the participant, it is possible that exposures might have occurred through both skin contact and inhalation. Although SEs, as superantigens, typically require lower concentrations than common household allergens to exert a response and exposures in the microgram range can be fatal independent of allergic sensitization, E10 the dose-response and chronic effects from environmental SE exposures are not well understood.
In this study increases in concentrations of 1 or more of the measured home dust SEs (SEA, SEB, and SEC) were associated with more days of slowed activity caused by asthma but not with FENO values or lung function. The magnitude and significance of the estimates of association with respiratory symptoms for total SEs were smaller than the estimates for individual SEs, which suggested that there was little evidence for an additive effect when SEs were considered in aggregate. These results were robust to inclusion of the number of positive skin prick test responses and presence of other home dust allergens, which suggested that any observed associations were independent of atopic status or allergen exposure.
Given that responsiveness to environmental exposures can depend on host factors, we next evaluated whether history of eczema modified the relationships between SE exposures and respiratory outcomes (see Fig 1 and Table E5 ). We identified that environmental SEA exposures were consistently associated with worse asthma among adolescents without a history of eczema. In contrast, SEB exposures were inconsistently associated with worse asthma among adolescents with a history of eczema. Prior studies have demonstrated that the severity of atopic dermatitis was associated with sensitization to SEB more so than SEA.
E17,E18 Furthermore, those with atopic eczema/dermatitis syndrome have been shown to have increased susceptibility to S aureus, potentially through host-specific superantigen stimulation of IL-5. E19 This led us to hypothesize that children and adolescents who reported a history of eczema would experience worse symptoms with increasing concentrations of home dust SEs. In contrast, we identified that the opposite was true, where participants who did not report a history of eczema had consistently worse asthma when exposed to home environmental SEA. It is possible that these observed associations were related to an IgE-dependent biological mechanism involving differential sensitization to individual SEs in this cohort; however, insufficient remainder serum from the prerandomization period was available to test SE-specific IgE concentrations directly in the ACE population.
House occupants are a source of bacteria, particularly S aureus, to the home environment E20 ; therefore it is possible that these results are a surrogate for current or recent S aureus/SE nasal colonization of participants and that nasal colonization, instead of environmental exposure, is associated with respiratory outcomes. Interestingly, mouse studies have shown the potential for SEA-carrying strains to be associated with increases in S aureus nasal colonization density, whereas SEB-carrying strains were associated with decreases in S aureus nasal colonization density. E21 Whether colonization density affects the relationship between S aureus and SE exposure and asthma outcomes or affects host shedding of S aureus and SE into an environmental reservoir is unknown. In addition, environmental S aureus contamination can be associated with recurrent infection in patients, E22 suggesting the potential for the environment to serve as a reservoir or amplifier of S aureus and SE exposures over time. Such re-enforcing cyclic drivers of asthma morbidity might be difficult to unpack.
Regardless, S aureus has been shown to persist in home environments over weeks to months, E23 and therefore it is unlikely that S aureus and SE exposures at the home visit would have changed in the 3-week or less period between the home visit and the randomization visit at which the outcomes were assessed. It is possible that, if S aureus and SE exposures affect asthma through an inflammatory mechanism, as hypothesized, assessment of outcomes after participants had completed a run-in period to optimize their controller medication regimen might have dampened the observed associations. It is also possible that other unmeasured confounders could explain the observed associations. This study was cross-sectional, which limits causal inference. Longitudinal studies that assess host SE plus S aureus colonization and host SE-specific IgE responses in conjunction with home environmental assessment will be needed to better understand the causal direction of this possible association.
We observed significant positive associations between Bla g 1 (cockroach) allergen concentrations and SEB and SEC exposures, significant negative associations between Fel d 1 (cat) and the same SE exposures (SEB and SEC), and significant negative associations between Can f 1 (dog) allergen concentrations and SA exposures. Although little is known about the microbial carriage of household cockroaches, they have the potential to carry S aureus. E24 The identification of a negative association with pets is in keeping with the literature demonstrating that dogs and cats less commonly become colonized with S aureus, even in the presence of a pet owner with skin or soft-tissue infection. E25 At the same time, our finding is interesting in light of a prior report that being a pet owner and having IgE to dog dander were associated with SEB sensitization (IgE) among adults with asthma in Japan. E26 Elucidating whether the effect is different in adolescents or whether polysensitization between SEB and other allergens, as has been suggested, E27 explains the prior findings is an important area for future research.
In this study we evaluated gene detection as a proxy for the presence of intrinsic and secreted protein products (potential allergens) from S aureus. Although gene presence does not necessarily indicate the presence of viable bacteria or secretion of the gene product, use of bacterial genes for microbial exposure assessment is a common surrogate, such as in studies of the microbiome. E28 A prior study that used gene detection as the gold standard for evaluation of a test for the presence of SEA proteins in food identified 100% correlation between detection of SEA protein and the SEA gene. E29 Furthermore, enterotoxins are known to be environmentally stable and resist desiccation, E10 supporting the potential for these proteins to persist in home dust. Intriguingly, sodium dodecylsulfate, a denaturing agent found in many common household cleaning and personal care products, has been shown to lead to partial unfolding of SEA proteins, resulting in an increase in T-cell proliferation and immunoreactivity. E30 The effects of household chemicals present in home dust and the effect of other environmental stressors on SE genes carrying S aureus secretion of SE proteins is unknown. It is also possible that immune effects occur through contact with the organism or with the genetic material itself, although these mechanisms are less likely. Development of methods to characterize SE proteins in airborne and settled home dust would be valuable to assess potential mechanisms by which these environmental exposures could affect asthma control.
Given the potential for S aureus and SE exposures to be common, even ubiquitous, in the home environment, even if a small risk for worse asthma given such exposures is identified, the population attributable risk could be large. This points to the importance of future studies to test this hypothesis further.
Portions of this work were presented previously at the American Academy of Allergy, Asthma & Immunology 2016 conference. Pearson correlation coefficients were based on log-transformed gene counts and allergen concentrations. *P < .05. P < .01. 
